Janet L. Kwiatkowski

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski et al. · New England Journal of Medicine · 2018 · 646 citations · Full text

Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia

Michael R. DeBaun, Mae O. Gordon, Robert C. McKinstry et al. · New England Journal of Medicine · 2014 · 523 citations · Full text

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 496 citations · Full text

Pediatric Hematology, Hematology, Neurological Monitoring +10

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support

Stella T. Chou, Mouaz Alsawas, Ross M. Fasano et al. · Blood Advances · 2020 · 427 citations · Full text

High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.

Angelika Eggert, Naohiko Ikegaki, Janet L. Kwiatkowski et al. · PubMed · 2000 · 312 citations

Pathology, Growth Factor Alpha, High-level Expression +16